Human Hair Keratin-Based Hydrogels in Regenerative Medicine: Current Status and Future Directions

    September 2023 in “ ACS Biomaterials Science & Engineering ”
    Mymuna Ashna, Neeharika Senthilkumar, Pallab Sanpui
    Image of study
    TLDR Human hair keratin hydrogels show promise for use in regenerative medicine.
    Regenerative medicine (RM) uses the regenerative potential of human cells to create functional human cells, tissues, and organs. A key component of RM is a biomaterial scaffold with the right physicochemical properties. Hydrogels, which can be made from synthetic polymers or biopolymers, have become a popular choice for tissue engineering and RM applications. They can be used as scaffolds for spatial patterning, delivering therapeutic agents, or substrates to enhance cell growth, differentiation, and migration. Biopolymers are preferred for their biocompatibility. Keratins, fibrous proteins, have recently been used to construct hydrogels for RM. This review focuses on the use of human hair keratin hydrogels in various RM applications.
    Discuss this study in the Community →

    Research cited in this study

    16 / 16 results

    Related Community Posts Join

    6 / 329 results

      community Verteporfin and Microneedling

      in Treatments 1 year ago
      Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.

      community Federal Grant Cuts have impacted PP405 related research

      in Technology  458 upvotes 2 months ago
      Federal funding cuts have delayed PP405 research, affecting hair loss treatment progress, though clinical trials will continue. The discussion highlights PP405's potential compared to minoxidil and finasteride and stresses the importance of government-funded research.

      community Has anyone else seen this encouraging verteporfin case study?

      in Progress Pictures  36 upvotes 1 year ago
      The conversation discusses the potential use of verteporfin for hair loss treatment, with one user mentioning their surgeon's interest in trying it and another noting its research status and clinical use as a YAP inhibitor. Some users debate the market size, availability of generics, and the optimism in the hair loss community regarding new treatments.

      community New Study: PP405, developed by Pelage Pharmaceuticals, can reactivate dormant hair follicle stem cells and stimulate natural hair growth by 20%

      in Research/Science  844 upvotes 2 months ago
      PP405, developed by Pelage Pharmaceuticals, can reactivate dormant hair follicle stem cells and increase hair growth by 20% in eight weeks, unlike minoxidil or finasteride. However, skepticism remains about its effectiveness and availability, with concerns about funding and the timeline for broader access.

      community Petition: Make PP405 available tomorrow instead of 2030

      in Satire  325 upvotes 4 months ago
      PP405, a promising hair loss treatment, is expected to be available by 2027, with faster trials due to its topical nature. Users are eager for its release, comparing it to existing treatments like minoxidil and finasteride, but remain cautious about its long-term effectiveness.

    Similar Research

    5 / 1000+ results